Search

everythinglearnresearchcommunity

for

Search:↓

Hair grows faster in the morning and is more vulnerable to damage from radiation due to the internal clock in hair follicle cells.

The document concludes that hair is complex, with a detailed growth cycle, structure, and clinical importance, affecting various scientific and medical fields.

Different soft tissue fillers can cause various skin reactions; biodegradable fillers are safer and non-biodegradable ones like silicone can lead to long-term problems.

The document concludes that specific itchy skin diseases during pregnancy have varying fetal risks and treatments, including corticosteroids and other medications.

New methods for skin and nerve regeneration can improve healing and feeling after burns.

Smart biomaterials that guide tissue repair are key for future medical treatments.

Toxic epidermal necrolysis is a severe skin condition often caused by drugs, with complex treatment and a high risk of death, but survivors usually heal without scars.

Fat-derived stem cells, platelet-rich plasma, and biomaterials show promise for healing chronic skin wounds and improving soft tissue with few side effects.

PRP shows promise for hair loss treatment, with three initial monthly injections and maintenance every 3-6 months.

Advancements in creating skin grafts with biomaterials and stem cells are promising, but more research is needed for clinical application.

Some drugs can cause hair loss, excessive growth, or color changes, often reversible but sometimes permanent.

Mice are useful for researching human hair loss and testing treatments, despite some differences between species.

Human hair follicle dermal cells can effectively replace other cells in engineered skin.

Pregnancy can cause specific skin conditions that need correct diagnosis and treatment to protect both mother and baby.

The document concludes that inherited epidermolysis bullosa is a challenging genetic condition requiring multidisciplinary care and new treatments.

The document concludes that freeze-dried platelet-rich plasma shows promise for medical use but requires standardization and further research.

New skin substitutes for treating severe burns and chronic wounds are being developed, but a permanent solution for deep wounds is not yet available commercially.

Further research is needed to improve hair regeneration using stem cells and nanomaterials.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

Artificial skin is improving wound healing and shows potential for treating different types of wounds.

Male hormones worsen kidney transplant damage, but blocking them helps.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

Mesenchymal stem cells, especially injected into the skin, heal wounds faster and better than chitosan gel or other treatments.

Platelet-based therapies using a patient's own blood show promise for skin and hair regeneration but require more research for confirmation.

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.

GFP transgenic mice help study cell origins in skin grafts.

Use PRP and ASC-BT for hair loss and wound healing, but more research needed.

Canine epidermal neural crest stem cells could be a promising treatment for spinal cord injuries in dogs.

The document concludes that careful surgical methods and choosing the right materials are key for successful scalp, skull, and frontal sinus reconstruction.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.